Filter
496
Text search:
pharmaceutical
policies
Featured
Recommendations
47
New Publications
123
Language
Document type
No document type
245
Studies & Reports
115
Guidelines
72
Strategic & Response Plan
29
Manuals
15
Training Material
6
Situation Updates
4
Fact sheets
4
Brochures
3
Resource Platforms
3
Countries / Regions
Ethiopia
30
Kenya
28
Global
20
India
15
Western and Central Europe
14
South Africa
12
Nigeria
11
Uganda
10
Rwanda
10
Ghana
9
Malawi
9
Sierra Leone
8
Zambia
8
Africa
8
Eastern Europe
8
Zimbabwe
7
Tanzania
7
Liberia
6
Philippines
6
Senegal
5
Syria
5
Namibia
5
Nepal
4
Bangladesh
4
Ukraine
4
South–East Asia Region
4
Congo, Democratic Republic of
3
Cameroon
3
South Sudan
2
Indonesia
2
Sudan
2
Lesotho
2
East and Southern Africa
2
West and Central Africa
2
Middle East and North Africa
2
Albania
2
Mali
1
Niger
1
Haiti
1
Pakistan
1
Jordan
1
Germany
1
Chad
1
Cambodia
1
Thailand
1
Mozambique
1
Papua New Guinea
1
Benin
1
Eswatini/ Swaziland
1
Brazil
1
North Macedonia
1
Botswana
1
Chile
1
Western Pacific Region
1
Latin America and the Carribbean
1
Asia
1
Fiji
1
Venezuela
1
Timor Leste/ East Timor
1
Lithuania
1
Iran
1
Vietnam
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
223
Key Resources
25
Clinical Guidelines
24
Public Health
21
Women & Child Health
11
Pharmacy & Technologies
8
Capacity Building
3
Toolboxes
AMR
58
COVID-19
51
Pharmacy
35
TB
30
HIV
27
Mental Health
24
NTDs
12
Rapid Response
11
NCDs
11
Global Health Education
9
Caregiver
9
Planetary Health
9
Health Financing Toolbox
7
Conflict
6
Disability
4
Ebola & Marburg
4
2.0 Rapid Response
4
Zika
3
Refugee
2
Specific Hazards
2
Cholera
1
Polio
1
Natural Hazards
1
Malaria
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th
...
Health Evidence Network synthesis report 72
UNAIDS 2017 / Reference
Generating evidence for policy and action on HIV and social protection
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
As a lower-middle-income country (LMIC), South Africa (SA) bears
the burden of maternal and neonatal mortality similar to other sub-
Saharan African countries. According to the Saving Mothers Report
2017/19, there has been a progressive and sustained reduction
in institutional maternal mortality
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c
...
The protection of children and educational facilities is particularly important. Precautions are necessary to prevent the potential spread of COVID-19 in school settings; however, care must also be taken to avoid stigmatizing students and staff who may have been exposed to the virus. It is important
...
Lancet Global Health Volume 7, Issue 1, January 2019, Pages e81-e95
Essential Drug list on page 36!!
